This company has been acquired
Apollo Endosurgery Crecimiento futuro
Future controles de criterios 2/6
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 17.4% |
| Tasa de crecimiento de los ingresos | 32.1% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 05 Apr 2023 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?
Aug 05Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings
Aug 04Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Mar 02Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?
Aug 04Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy
Jun 28Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?
May 05Apollo Endosurgery EPS beats by $0.05, beats on revenue
May 04A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)
Mar 24What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?
Mar 03Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares
Feb 10We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt
Jan 31Assessing Apollo Endosurgery
Dec 27If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%
Dec 27Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?
Dec 01Apollo Endosurgery EPS beats by $0.10, beats on revenue
Nov 05Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2025 | 181 | N/A | -31 | N/A | 1 |
| 12/31/2024 | 117 | N/A | -28 | N/A | 1 |
| 12/31/2023 | 89 | -34 | -30 | N/A | 2 |
| 12/31/2022 | 77 | -40 | -34 | -31 | N/A |
| 9/30/2022 | 72 | -41 | -28 | -25 | N/A |
| 6/30/2022 | 68 | -36 | -25 | -23 | N/A |
| 3/31/2022 | 66 | -28 | -21 | -19 | N/A |
| 12/31/2021 | 63 | -25 | -16 | -14 | N/A |
| 9/30/2021 | 60 | -18 | -14 | -13 | N/A |
| 6/30/2021 | 56 | -14 | -15 | -14 | N/A |
| 3/31/2021 | 45 | -17 | -19 | -19 | N/A |
| 12/31/2020 | 42 | -23 | -21 | -21 | N/A |
| 9/30/2020 | 41 | -26 | -26 | -25 | N/A |
| 6/30/2020 | 40 | -32 | -27 | -26 | N/A |
| 3/31/2020 | 48 | -35 | -27 | -26 | N/A |
| 12/31/2019 | 51 | -27 | -27 | -26 | N/A |
| 9/30/2019 | 54 | -39 | -24 | -23 | N/A |
| 6/30/2019 | 57 | -40 | -21 | -20 | N/A |
| 3/31/2019 | 58 | -40 | -24 | -22 | N/A |
| 12/31/2018 | 61 | -46 | -26 | -23 | N/A |
| 9/30/2018 | 62 | -35 | -26 | -23 | N/A |
| 6/30/2018 | 64 | -30 | -27 | -24 | N/A |
| 3/31/2018 | 66 | -27 | -20 | -17 | N/A |
| 12/31/2017 | 64 | -27 | -15 | -13 | N/A |
| 9/30/2017 | 64 | -33 | -18 | -16 | N/A |
| 6/30/2017 | 63 | -36 | -16 | -14 | N/A |
| 3/31/2017 | 63 | -41 | -14 | -12 | N/A |
| 12/31/2016 | 65 | -41 | -15 | -13 | N/A |
| 9/30/2016 | 66 | -36 | N/A | -8 | N/A |
| 6/30/2016 | 66 | -38 | N/A | -7 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Insufficient data to determine if APEN's forecast earnings growth is above the savings rate (2.1%).
Beneficios vs. Mercado: Insufficient data to determine if APEN's earnings are forecast to grow faster than the US market
Beneficios de alto crecimiento: Insufficient data to determine if APEN's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: APEN's revenue (32.1% per year) is forecast to grow faster than the US market (6.9% per year).
Ingresos de alto crecimiento: APEN's revenue (32.1% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if APEN's Return on Equity is forecast to be high in 3 years time